Endurant Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-32,371
| Closed | -$672K | – | 51 |
|
|
2018
Q3 | $672K | Buy |
+32,371
| New | +$672K | 0.3% | 55 |
|
|
2016
Q1 | – | Sell |
-10,010
| Closed | -$357K | – | 87 |
|
|
2015
Q4 | $357K | Buy |
10,010
+310
| +3% | +$11.1K | 0.12% | 75 |
|
|
2015
Q3 | $321K | Sell |
9,700
-5,300
| -35% | -$175K | 0.11% | 73 |
|
|
2015
Q2 | $628K | Buy |
+15,000
| New | +$628K | 0.19% | 80 |
|